Kassira Wealth Management LLC Reduces Position in SPDR S&P Biotech ETF $XBI

Kassira Wealth Management LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,943 shares of the exchange traded fund’s stock after selling 7,260 shares during the period. SPDR S&P Biotech ETF accounts for approximately 1.8% of Kassira Wealth Management LLC’s investment portfolio, making the stock its 19th biggest holding. Kassira Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,944,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Ballast Advisors LLC acquired a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $36,000. Barnes Dennig Private Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $48,000. Citizens National Bank Trust Department purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $50,000. MMA Asset Management LLC purchased a new stake in SPDR S&P Biotech ETF in the third quarter valued at approximately $59,000. Finally, Pier 88 Investment Partners LLC acquired a new position in SPDR S&P Biotech ETF in the 3rd quarter worth approximately $60,000.

SPDR S&P Biotech ETF Trading Down 2.9%

XBI opened at $133.66 on Friday. SPDR S&P Biotech ETF has a 12-month low of $75.68 and a 12-month high of $139.19. The firm has a market capitalization of $8.53 billion, a PE ratio of 11.47 and a beta of 0.85. The firm has a 50 day moving average of $128.47 and a two-hundred day moving average of $123.44.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.